Salud financiera de hoja de balance de Turnstone Biologics
Salud financiera controles de criterios 4/6
Turnstone Biologics has a total shareholder equity of $59.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $76.9M and $17.1M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$62.40m |
| Patrimonio | US$59.74m |
| Total pasivo | US$17.14m |
| Activos totales | US$76.88m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: TSBX's short term assets ($68.4M) exceed its short term liabilities ($15.6M).
Pasivo a largo plazo: TSBX's short term assets ($68.4M) exceed its long term liabilities ($1.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: TSBX is debt free.
Reducción de la deuda: TSBX has not had any debt for past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: TSBX has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: TSBX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.3% each year